Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
Search by expertise, name or affiliation
Treatment of the hematological manifestations of dyskeratosis congenita
C. Putterman
, R. Safadi
, J. Zlotogora
, R. Banura
, A. Eldor
Hadassah University Medical Centre
Beit Jalla Hospital
Research output
:
Contribution to journal
›
Article
›
peer-review
20
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of the hematological manifestations of dyskeratosis congenita'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hematological Manifestations
100%
Dyskeratosis Congenita
100%
Etiology
25%
Recombinant
25%
Granulocyte Colony-stimulating Factor (G-CSF)
25%
Poor Prognosis
25%
Therapeutic Potential
25%
Multisystem Disease
25%
Transient Performance Improvement
25%
Life-threatening Infections
25%
Skin pigmentation
25%
Dystrophic Nails
25%
Severe Aplastic Anemia
25%
Pancytopenia
25%
Leukoplakia
25%
Hematological Abnormalities
25%
Absolute Neutrophil Count
25%
Pharmacology, Toxicology and Pharmaceutical Science
Dyskeratosis Congenita
100%
Infection
25%
Recombinant Granulocyte Macrophage Colony Stimulating Factor
25%
Aplastic Anemia
25%
Disease
25%
Pancytopenia
25%
Leukoplakia
25%
Biochemistry, Genetics and Molecular Biology
Dyskeratosis Congenita
100%
Absolute Neutrophil Count
25%
Skin Pigmentation
25%
Granulocyte Macrophage Colony-Stimulating Factor
25%